Cryotherapy Market Size and Share

Cryotherapy Market Analysis by Mordor Intelligence
The Cryotherapy Market size is expected to increase from USD 322.04 million in 2025 to USD 339.94 million in 2026 and reach USD 464.61 million by 2031, growing at a CAGR of 6.45% over 2026-2031.
Accelerated replacement of liquid-nitrogen chambers with fully electric systems has started to re-shape cost structures, because clinics shed recurring gas deliveries and ventilation retrofits.[1]CryoBuilt Team, “Polaris Electric Chamber Cuts Five-Year Cost 60%,” CryoBuilt, cryobuilt.com Fitness-club installations, mobile rental fleets, and home devices are widening access beyond sports-medicine clinics, creating fresh demand for consumable-light hardware and software subscriptions. Oncology and pain-management reimbursements in North America provide a medical pathway for localized cryoablation, while aesthetics-oriented spot-cooling devices flourish in cash-pay channels.[2]American Medical Association, “CPT 64624 for Cryoneurolysis,” AMA, ama-assn.org Competitive dynamics emphasize AI-enabled temperature control and throughput optimization rather than ever-lower chamber temperatures, signaling a pivot toward data-rich user experiences.
Key Report Takeaways
- By product and services, whole-body cryochambers led with 49.13% revenue share in 2025; hybrid and mobile units are projected to post the fastest 10.63% CAGR to 2031.
- By application, sports recovery accounted for 33.45% share in 2025, while dermatology and aesthetics is forecast to expand at a 9.24% CAGR through 2031.
- By end user, hospitals and specialty clinics held 43.76% spending share in 2025; home-use and direct-to-consumer devices are expected to grow at a 10.53% CAGR over 2026-2031.
- By technology, liquid-nitrogen systems commanded 56.84% revenue share in 2025, whereas fully electric platforms are poised for the highest 8.23% CAGR to 2031.
- By geography, North America dominated with 37.83% revenue share in 2025; Asia-Pacific is anticipated to register the quickest 7.74% CAGR during the forecast period.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Global Cryotherapy Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rapid Shift from Liquid Nitrogen to Fully-Electric Cryo-Systems Cut Costs | 1.2% | Global, with early adoption in EU and North America | Medium term (2-4 years) |
| Reimbursement Expansion in Key Regions | 0.9% | North America, select EU markets | Long term (≥ 4 years) |
| Increased Cryo Access in Fitness Clubs | 0.8% | North America, Asia-Pacific urban centers | Short term (≤ 2 years) |
| AI-Driven Chambers Enhance Throughput | 0.6% | Global, concentrated in premium clinics | Medium term (2-4 years) |
| Rental Market Growth with Mobile Cryo-Vans | 0.7% | North America, Western Europe | Short term (≤ 2 years) |
| Fat-Reduction Demand Spurs Cryo Adoption | 1.0% | Global, strongest in North America and Asia-Pacific | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Rapid Shift From Liquid-Nitrogen to Fully-Electric Cryo-Systems Cut Costs
Clinics switching to electric chambers remove weekly dewar deliveries, lower insurance premiums linked to pressurized-gas storage, and meet net-zero mandates in the European Union and California. CryoBuilt’s Polaris electric chamber demonstrated a 60% reduction in five-year operating cost compared with nitrogen models. The transition accelerates in regions with unstable gas logistics, enabling new operators in Southeast Asia and Latin America to enter the cryotherapy market without specialized supply chains. Facility managers also favor electric units because they bypass OSHA oxygen-monitor requirements. Collectively, these shifts add 1.2 percentage points to forecast CAGR by broadening the serviceable venue base and raising replacement demand.
Reimbursement Expansion in Key Regions
The American Medical Association introduced CPT 64624 in 2024, legitimizing cryoneurolysis billing and prompting capital purchases in pain clinics. Germany’s insurers began reimbursing whole-body cryotherapy for rheumatoid arthritis under pilot programs in 2025, signaling a European precedent. Although the U.S. Centers for Medicare & Medicaid Services still classifies whole-body cryo as investigational,[3]Centers for Medicare & Medicaid Services, “Coverage Determination for Whole-Body Cryotherapy (E0218),” CMS, cms.gov partial reimbursement steers investment toward localized medical devices that enjoy procedural fees. Over the long term, consistent payer recognition could inject nearly 1 percentage point into the global CAGR, especially if more Payors align on chronic-pain indications.
Increased Cryo Access in Fitness Clubs
Premium gym chains add three-minute cryo sessions to memberships to lock in higher monthly fees and drive secondary spending on recovery services. Equinox installed cryochambers in 12 U.S. clubs during 2025, bundling unlimited sessions into USD 300 packages that reach wellness-oriented consumers who previously avoided stand-alone clinics. Similar rollouts in Seoul and Tokyo expand exposure among office workers. The club route normalizes cryotherapy as routine recovery rather than specialized therapy, lifting session volumes and supporting a +0.8% impact on CAGR through new user acquisition.
AI-Driven Chambers Enhance Throughput
MECOTEC’s CryoStar system senses skin temperature and dynamically modulates cooling intensity, reducing cycle variance by 40% while doubling hourly client capacity. Automated logs ease ISO 9001 audits, strengthening hospital adoption. Although AI chambers carry premium price tags now, component costs fall as edge-AI chips commoditize. Higher throughput boosts revenue per square foot, incentivizing chain operators to upgrade and nudging CAGR upward by 0.6%.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising Gas Prices Increase Risks | -0.8% | Europe, Asia-Pacific regions dependent on LNG imports | Short term (≤ 2 years) |
| Insurer Pushback Due to Lack of Standards Benchmarking Study | -0.6% | North America, select EU markets | Long term (≥ 4 years) |
| Tariffs Impact Mobile Chamber Costs | -0.5% | North America, import-dependent markets | Medium term (2-4 years) |
| High Costs Limit Adoption in Small Clinics | -0.7% | Global, most acute in emerging markets | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Rising Gas Prices Increase Risks
European nitrogen spot prices spiked above EUR 50 per MWh in late 2025, eroding margins at high-volume sports clinics and prompting deferred purchases of nitrogen-fed systems. Operators recalculated break-even analyses, delaying replacement cycles until electric alternatives become affordable. Similar volatility in Asia-Pacific LNG markets compresses budgets in Japan and South Korea. These conditions shave 0.8 percentage points off short-term growth.
Insurer Pushback Due to Lack of Standards Benchmarking Study
The American Academy of Physical Medicine and Rehabilitation highlighted wide variation in session protocols, complicating insurer evaluation. Absent consensus guidelines, Payors label whole-body cryotherapy experimental. The uncertainty forces clinics into cash-pay models, limiting volume in price-sensitive populations and dragging CAGR by 0.6 points over the long run.
Segment Analysis
By Product and Services: Hybrid Units Gain as Rental Fleets Expand
Whole-body cryochambers generated almost half of 2025 revenue, yet hybrid and mobile units will outpace at a 10.63% CAGR as rental operators send trailer-mounted systems to events and corporate campuses. The shift diversifies the cryotherapy market because customers with no capital budget can still provision sessions on demand.
Consumables revenue shrinks as the sector turns electric, but software subscriptions grow when operators use cloud dashboards to schedule sessions, track utilization, and document safety compliance. Localized devices hold roughly 18% share, driven by dermatology uptake for aesthetic spot treatments. Cryosurgery systems, vested mainly in oncology, maintain steady adoption inside interventional radiology suites. Accessories, including nitrogen dewars and thermal gloves, taper in lock-step with the electric transition, so vendors hedge by bundling maintenance contracts and analytics platforms. The evolving mix means chamber form-factors, not temperatures, define competitive advantage, intensifying a platform race across the cryotherapy market.

Note: Segment shares of all individual segments available upon report purchase
By Application: Aesthetics Outpace Traditional Recovery
Sports recovery retained 33.45% of the cryotherapy market size in 2025 thanks to elite teams and collegiate programs. Dermatology and aesthetics, however, add sessions faster, climbing 9.24% annually through 2031 on social-media visibility and financing plans.
Pain-management clinics deploy cryoneurolysis probes under CPT 64624, but reimbursement gaps cap statewide rollouts. Oncology usage broadens as imaging-guided cryoablation lowers collateral tissue damage, supporting steady unit placements inside tertiary hospitals. Wellness and weight-management kiosks remain fragmented yet visible in luxury resorts that position cryo as a metabolism booster. The application landscape shows recovery saturation in professional sports, so operators court amateur athletes, beauty seekers, and chronic-pain patients to enlarge the cryotherapy market.
By End User: Home Devices Disrupt Clinic Models
Hospitals and specialty clinics controlled 43.76% of 2025 spending, underpinned by reimbursable cryoneurolysis and oncology cases. Home-use devices, positioned below USD 5,000, clock a double-digit CAGR as affluent consumers bypass per-visit fees.
Sports and fitness centers fold cryo into premium memberships, softening churn in saturated metropolitan gyms. Destination wellness resorts curate multi-day detox packages featuring cold exposure, mindfulness, and IV therapy. The democratization of hardware forces clinics to differentiate through guided protocols, biometric dashboards, and integration with electronic health records, adding data resonance to the cryotherapy market share calculus.

Note: Segment shares of all individual segments available upon report purchase
By Technology: Electric Systems Erode Nitrogen’s Lead
Liquid-nitrogen systems preserved 56.84% revenue share in 2025 but face attrition as electric chambers mature. Electric units save USD 800-1,200 monthly in gas and skip OSHA ventilation mandates, raising the cryotherapy market size addressable to urban boutique studios.
Practitioners preferring sub-140 °C levels will cling to nitrogen systems in research and elite performance labs. CO₂ spot devices stay niche yet vital in dermatology because they require minimal room prep and cost only USD 2,000-5,000. Regulatory nudges like Germany’s Blue Angel eco-label and California’s Title 24 energy code incentivize electric adoption, plotting a measured but inexorable shift inside the cryotherapy market.
Geography Analysis
North America generated 37.83% of global revenue in 2025, with the United States comprising 85% of that figure on the back of pro-sports demand and early medical reimbursement. Canada and Mexico remain smaller but stable, supporting cash-pay models in Toronto, Vancouver, Monterrey, and Mexico City. FDA clearance of IceCure’s ProSense system for benign breast tumors signals regulatory momentum for minimally invasive cryoablation.
Asia-Pacific will expand the cryotherapy market at 7.74% through 2031 as China’s domestic builders undercut European imports by 30-40%. Japan rides aging-population demand for non-pharmacological pain relief despite absent reimbursement. India’s cricket academies and private hospitals in Mumbai and Bangalore buy chambers to serve professional and affluent amateur athletes. South Korea gravitates toward aesthetics in Seoul’s Gangnam district, while Australia focuses on sports recovery in Sydney and Melbourne. Fragmented rules and cultural preferences for traditional remedies slow uptake, but growing middle-class income and sports participation widen the user base.
In Europe, Germany led, aided by statutory insurers piloting cryo coverage for rheumatoid arthritis. France’s thalassotherapy spas and the United Kingdom’s Premier League clinics maintain robust demand. Italy and Spain add aesthetic and sports-rehab users respectively. Middle East and Africa collectively held about 6% share, dominated by UAE and Saudi Arabia luxury wellness centers. South America’s 5% share is concentrated in Brazil and Argentina, where private hospitals equip orthopedic wards. Together, these regional profiles underline differing adoption curves yet a converging preference for electric, data-rich hardware across the cryotherapy market.

Competitive Landscape
The cryotherapy market is moderately concentrated. Market leaders pursue vertical integration, as Boston Scientific absorbs probe suppliers for oncology ablation. Medtronic’s cryoablation line added USD 180 million to FY 2025 sales, leveraging hospital relationships and procedure-based billing.
Challengers focus on electric systems that eliminate nitrogen logistics. CryoBuilt and JUKA emphasize sustainability messaging to court eco-certified facilities. Patent trends steer toward AI-controlled temperature algorithms and modular chambers that switch between whole-body and localized modes. Home-use devices below USD 5,000 remain a white-space where incumbents have limited presence. Mobile fleet operators cultivate niche revenue at sporting events and corporate wellness activations, reinforcing a service-led layer within the cryotherapy industry.
Technology differentiation now centers on user-experience features—biometric tracking, smartphone connectivity, and EHR export—rather than ever-colder temperatures. Hospitals demand ISO-compliant logs, whereas consumer segments want gamified recovery metrics. Regulatory divergence sustains two strategic tracks: medical-grade devices chase FDA or CE approval, and wellness brands exploit cash-pay channels aided by influencer marketing. Consolidation pressure likely rises in the medical segment as compliance burdens escalate, but low barriers keep the wellness side fragmented, preserving competitive diversity inside the cryotherapy market.
Cryotherapy Industry Leaders
Zimmer MedizinSysteme GmbH
MECOTEC GmbH
Cryomed s.r.o
Impact Cryotherapy Inc.
CRYO Science
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- January 2026: VeCura ReSculpt launched in Hyderabad, pairing non-surgical body sculpting with whole-body cryotherapy.
- November 2025: CryoTherapeutics partnered with SpectraWAVE and the Cardiovascular Research Foundation on the ICECAP clinical study for coronary plaque treatment.
- September 2025: Bonphul Air Products debuted Bonphul Cryogen, the first India-manufactured cryotherapy system for clinical and wellness customers.
Global Cryotherapy Market Report Scope
As per the scope of the report, Cryotherapy, or "cold therapy," is a therapeutic technique that uses extremely low temperatures to treat tissue lesions, reduce inflammation, alleviate pain, and destroy abnormal tissues like tumors.
The Cryotherapy Market Report is segmented by Product and Services, Application, End User, Technology, and Geography. By Product and Services, the market is segmented into Whole‑Body Cryochambers, Localised Devices, Cryosurgery Systems, Hybrid/Mobile Units, Accessories and Consumables, and Software and Services. By Application, the market is segmented into Sports Recovery, Pain Management, Oncology, Dermatology & Aesthetics, and Wellness & Weight‑Management. By End User, the market is segmented into Hospitals & Specialty Clinics, Sports & Fitness Centers, Wellness & Spa Facilities, and Home‑Use/Direct‑to‑Consumer. By Technology, the market is segmented into Liquid‑Nitrogen Systems, Fully‑Electric Systems, and CO₂ Spot‑Therapy Devices. By Geography, the market is segmented into North America, Europe, Asia‑Pacific, Middle East & Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. Market Forecasts are Provided in Terms of Value (USD).
| Whole-Body Cryochambers |
| Localised Devices |
| Cryosurgery Systems |
| Hybrid / Mobile Units |
| Accessories and Conusmables |
| Software and Services |
| Sports Recovery |
| Pain Management |
| Oncology (Cryo-ablation) |
| Dermatology & Aesthetics |
| Wellness & Weight-Management |
| Hospitals & Specialty Clinics |
| Sports & Fitness Centers |
| Wellness & Spa Facilities |
| Home-Use / Direct-to-Consumer |
| Liquid-Nitrogen Systems |
| Fully-Electric Systems |
| CO₂ Spot-Therapy Devices |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| France | |
| United Kingdom | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| South Korea | |
| Australia | |
| Rest of Asia-Pacific | |
| Middle East & Africa | GCC |
| South Africa | |
| Rest of Middle East & Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Product and Services | Whole-Body Cryochambers | |
| Localised Devices | ||
| Cryosurgery Systems | ||
| Hybrid / Mobile Units | ||
| Accessories and Conusmables | ||
| Software and Services | ||
| By Application | Sports Recovery | |
| Pain Management | ||
| Oncology (Cryo-ablation) | ||
| Dermatology & Aesthetics | ||
| Wellness & Weight-Management | ||
| By End User | Hospitals & Specialty Clinics | |
| Sports & Fitness Centers | ||
| Wellness & Spa Facilities | ||
| Home-Use / Direct-to-Consumer | ||
| By Technology | Liquid-Nitrogen Systems | |
| Fully-Electric Systems | ||
| CO₂ Spot-Therapy Devices | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| France | ||
| United Kingdom | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| South Korea | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| Middle East & Africa | GCC | |
| South Africa | ||
| Rest of Middle East & Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
How fast will global cryotherapy revenues grow through 2031?
The cryotherapy market is forecast to expand at a 6.45% CAGR from 2026 to 2031, reaching USD 464.61 million.
Which technology is replacing liquid-nitrogen chambers?
Fully electric systems are growing at an 8.23% CAGR because they eliminate gas costs and meet sustainability mandates.
What segment holds the largest cryotherapy market share today?
Whole-body cryochambers led with 49.13% share in 2025.
Where is regional growth strongest after North America?
Asia-Pacific is projected to post a 7.74% CAGR through 2031, buoyed by lower-cost domestic manufacturers in China.
Are home cryotherapy devices economically viable for consumers?
Yes, devices priced below USD 5,000 can break even after 30-50 sessions compared with clinic fees.
What is the key reimbursement milestone for cryoneurolysis?
AMA CPT 64624, introduced in 2024, allows U.S. providers to bill Medicare and private insurers for peripheral-nerve cryoablation.




